A detailed history of Virtus Investment Advisers, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 18,458 shares of INVA stock, worth $329,290. This represents 0.3% of its overall portfolio holdings.

Number of Shares
18,458
Previous 18,458 -0.0%
Holding current value
$329,290
Previous $302,000 17.88%
% of portfolio
0.3%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$14.56 - $16.78 $203,840 - $234,920
-14,000 Reduced 43.13%
18,458 $281,000
Q1 2023

May 15, 2023

SELL
$10.73 - $13.6 $11,996 - $15,204
-1,118 Reduced 3.33%
32,458 $365,000
Q4 2022

Feb 14, 2023

BUY
$11.8 - $13.78 $396,196 - $462,677
33,576 New
33,576 $444,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.